Castle Biosciences, Inc.
METHODS OF DIAGNOSING AND TREATING PATIENTS WITH CUTANEOUS SQUAMOUS CELL CARCINOMA
Last updated:
Abstract:
The present disclosure relates to methods for predicting the risk of recurrence and/or metastasis, or both in primary cutaneous squamous cell carcinoma (cSCC).
Status:
Application
Type:
Utility
Filling date:
14 Aug 2020
Issue date:
5 Aug 2021